Skip to main content
SpringerLink
Log in

Sorafenib

Squamous cell carcinoma: 15 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Smith KJ, Haley H, Hamza S, Skelton HG.Eruptive keratoacanthoma-type squamous cell carcinomas in patients taking sorafenib for the treatment of solid tumors. Dermatologic Surgery 35: 1766-1770, No. 11, 2009. Available from: URL: http://dx.doi.org/10.1111/j.1524-4725.2009.01289.x - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sorafenib. React. Wkly. 1290, 43 (2010). https://doi.org/10.2165/00128415-201012900-00137

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201012900-00137

Keywords

Search

Navigation